Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Shyam Patel

Assistant Professor

University of Massachusetts Chan Medical School

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

About

Shyam Patel is an Assistant Professor at the University of Massachusetts Medical School, located in the United States. His research focuses on hematology, particularly in the areas of myeloid neoplasms, acute myeloid leukemia, and myelodysplastic syndromes. Dr. Patel has contributed significantly to the understanding of treatment patterns, survival outcomes, and the genetics of hematological malignancies, as evidenced by his recent publications.

Articles (31)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (3)

Talha Badar

Leukemia Attending

Mayo Clinic Florida

UNITED STATES

View details

Evan Chen

Dana-Farber Cancer Institute

UNITED STATES

View details

Lachelle Dawn Weeks

Dana-Farber Cancer Institute

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Shyam Patel

Research Interests

Explore related searches

About

Articles (31)

Contemporary Clinical Outcomes and Healthcare Utilization in Older Adults with Acute Myeloid Leukemia: Insights from a Single-Center Retrospective Cohort

Limited Survival Benefit and High Healthcare Utilization With AML‐Directed Therapy in Older Patients With TP53‐Mutated Acute Myeloid Leukemia

Menin Inhibitors in Acute Myeloid Leukemia: Clinical Integration, Resistance, and the Path Beyond Monotherapy

Synthetic lethality in TP53-mutant acute myeloid leukemia

Ontogeny and Natural History of Therapy‐Related Clonal Hematopoiesis From a Multidisciplinary CHIP Clinic

Modern Concepts in Precision Targeting of Acute Myeloid Leukemia Based on Principles of Molecular Oncology

CHIP clinics: a practical overview of structure and function

Challenges and Solutions to Implementation of Chimeric Antigen Receptor Therapies in Acute Myeloid Leukemia

A proposal for expedited stem cell transplantation for TP53-mutant myelodysplastic neoplasms and acute myeloid leukemia

Clinico-genomic characterization of RAS-mutant acute myeloid leukemia

Outcomes of adults older than 70 years of age undergoing allogeneic stem cell transplantation

Treatment patterns and survival outcomes for very elderly patients with acute myeloid leukemia: A National Cancer Database study

The evolving nosology of myeloid neoplasms: the semi-centennial of the 1976 French-American-British classification

Early identification of TP53 mutations and TP53 allelic state in myelodysplastic neoplasms and acute myeloid leukemia via point‐of‐care p53 immunohistochemistry

Contemporary management paradigms and emerging therapeutics for myelodysplastic syndromes/neoplasms

Expanding the Therapeutic Reach of Chimeric Antigen Receptor T-Cells and Bispecific T-Cell Engagers Across Solid Tumors

Drafting a blueprint for designing successful clinical trials in clonal haematopoiesis

Managing the unmanageable: evidence-driven approaches to real-world patient prototypes of TP53-mutant myelodysplastic neoplasms and acute myeloid leukemia

Effects of donor-engrafted clonal hematopoiesis in allogeneic and autologous stem cell transplantation: a systematic review and meta-analysis

Natural history of clonal haematopoiesis seen in real‐world haematology settings

The heart of VIALE‐A: Cardiac complications of hypomethylating agents and venetoclax in acute myeloid leukaemia

Prognostic heterogeneity and clonal dynamics within distinct subgroups of myelodysplastic syndrome and acute myeloid leukemia with TP53 disruptions

Precision and strategic targeting of novel mutation-specific vulnerabilities in acute myeloid leukemia: the semi-centennial of 7 + 3

Challenges and solutions to superior chimeric antigen receptor‐T design and deployment for B‐cell lymphomas

The emerging therapeutic landscape of relapsed/refractory multiple myeloma

The Novel Therapeutic Landscape for Relapsed/Refractory Diffuse Large B Cell Lymphoma

TP53-mutant myelodysplastic syndrome and acute myeloid leukemia: the black hole of hematology

Niche-directed therapy in acute myeloid leukemia: optimization of stem cell competition for niche occupancy

Clonal IgH gene rearrangements identify Richter’s transformation to diffuse large B cell lymphoma

Rapid and Deep Remission Induced by Blinatumomab for CD19-Positive Chronic Myeloid Leukemia in Lymphoid Blast Phase

Clinico-genomic profiling and clonal dynamic modeling of <i>TP53</i>-aberrant myelodysplastic syndrome and acute myeloid leukemia.

Collaborators (3)

Talha Badar

Evan Chen

Lachelle Dawn Weeks

Make your next move.